Denoyer Bernard 4

What Happened Denoyer Bernard, a director of OKYO Pharma Ltd (OKYO), received a grant of 3,500 derivative shares (an award) on 2026-06-08. The award is reported at an acquisition price of $1.85 per share, for a total reported value of $6,475. This is a compensation grant (code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-08; Form 4 filed: 2026-06-10 (timely filing).
• Grant size and price: 3,500 derivative shares @ $1.85 each = $6,475 total.
• Vesting: 25% per year over four years, beginning on the first anniversary of the grant date.
• Shares owned after transaction: not specified in the filing.
• Transaction type: Award/Grant of derivative securities (not a cash purchase or sale).

Context This is a standard equity-compensation grant to a director and should be read as part of routine company compensation practices rather than a direct buy or sell signal. Because the award is a derivative grant with multi-year vesting, the economic benefit vests over time rather than immediately.